Rowden Medical Partnership
About Rowden Medical Partnership
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Rowden Medical Partnership
During the past decade, Rowden Medical Partnership conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy Study of the Sorin 3D Annuloplasty Ring For Mitral Repair
2007-08-01
2013-06-01
Completed
278
Randomized Sizing and Hemodynamic Study Mitroflow vs. Magna
2008-06-01
2011-09-01
Terminated
368
A Carotid Stenting Boston Scientific Surveillance Program
2008-12-01
2010-10-01
Completed
1,097
Post-Approval Clinical Study of the Talent Thoracic Stent Graft to Treat Thoracic Aortic Aneurysms (THRIVE)
2009-04-01
2017-08-01
Terminated
349
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
2009-11-13
2017-12-31
Completed
2,204
Comparing Blood Loss, RBC Transfusions and Inflammatory Marker Changes Among Methods of CPB
2010-03-01
2011-09-01
Completed
102
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Rowden Medical Partnership" #1 sponsor was "Kowa Research Europe" with 4 trials, followed by "Abbott Diabetes Care" with 1 trials
sponsored, "Firstkind Ltd" with 1 trials sponsored, "George Medicines PTY Limited" with 1 trials sponsored and "Kitov Pharma Ltd"
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
Clinical Trials Conditions at Rowden Medical Partnership
According to Clinical.Site data, the most researched conditions in "Rowden Medical Partnership" are
"Hypertension" (3 trials), "Dyslipidemia" (2 trials), "Hypercholesterolemia" (2 trials), "Diabetes Mellitus" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Rowden Medical Partnership" in a lesser frequency.
Clinical Trials Intervention Types at Rowden Medical Partnership
Most popular intervention types in "Rowden Medical Partnership" are "Drug" (9 trials), "Device" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Pitavastatin" (4 trials), "Amlodipine 2.5 mg/indapamide 1.25 mg" (1 trials), "Atorvastatin" (1 trials), "Canakinumab" (1 trials) and "Dietary supplement (ONS)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Rowden Medical Partnership
The vast majority of trials in "Rowden Medical Partnership" are
12 trials for "All" genders.
Clinical Trials Status at Rowden Medical Partnership
Currently, there are NaN active trials in "Rowden Medical Partnership".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Rowden Medical Partnership,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Rowden Medical Partnership, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 3 trials that are defined as “Not Applicable".